SEI Investments’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$696K Buy
191,245
+16,200
+9% +$59K ﹤0.01% 2064
2025
Q1
$336K Buy
+175,045
New +$336K ﹤0.01% 2295
2021
Q1
Sell
-14,231
Closed -$37K 2468
2020
Q4
$37K Sell
14,231
-1,405
-9% -$3.65K ﹤0.01% 2441
2020
Q3
$38K Sell
15,636
-34,180
-69% -$83.1K ﹤0.01% 2381
2020
Q2
$675K Buy
49,816
+36,727
+281% +$498K ﹤0.01% 1722
2020
Q1
$97K Sell
13,089
-58
-0.4% -$430 ﹤0.01% 2260
2019
Q4
$81K Buy
13,147
+1,279
+11% +$7.88K ﹤0.01% 2344
2019
Q3
$45K Buy
+11,868
New +$45K ﹤0.01% 2349
2019
Q2
Sell
-8,661
Closed -$67K 2384
2019
Q1
$67K Sell
8,661
-29,062
-77% -$225K ﹤0.01% 2562
2018
Q4
$206K Buy
+37,723
New +$206K ﹤0.01% 2016
2018
Q2
Sell
-1,610
Closed -$15K 3600
2018
Q1
$15K Buy
1,610
+545
+51% +$5.08K ﹤0.01% 2735
2017
Q4
$16K Buy
1,065
+519
+95% +$7.8K ﹤0.01% 2664
2017
Q3
$11K Buy
+546
New +$11K ﹤0.01% 2659